Sarah Cannon Research Institute Is A Prominent Global Cancer Research Organization Founded In 1993 In Nashvilletennesseenamed After The Television Personality Minnie Pearlthe Institute Focuses On Advancing Cancer Care Through Clinical Trials And Innovative Therapiesit Was Formally Named In 2004 And Has Played A Significant Role In Drug Approvals And Patient Education The Institute Specializes In Conducting Clinical Trials Across All Phasesincluding First In Human Studiesand Is Recognized As One Of The Largest Patient Centric Clinical Trial Organizations Worldwidesarah Cannon Also Leads Community Based Drug Development Programs And Utilizes Molecular Diagnostics To Analyze Cancer At The Genetic Levelhelping To Optimize Treatment Strategieswith Partnerships Including Hca Healthcare And Tennessee Oncologysarah Cannon Has Expanded Its Reach To Various Locations In The United States And The United Kingdomits Mission Is To Enhance Cancer Care By Increasing Access To Clinical Trials And Innovative Therapiesultimately Benefiting A Broader Patient Population
